Home・Akciju saraksts・Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc

Slēgts

SektorsVeselības aprūpe

593.92 2.43

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

587.01

Max

594.02

Galvenie mērījumi
By Trading Economics
Ienākumi	85M 1.7B
Pārdošana	989M 12B
P/E Sektora vidējais	30.845 68.51
EPS	6.03
Dividenžu ienesīgums	0.31
Peļņas marža	14.516
Darbinieki	125,000
EBITDA	262M 2.6B

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt (spēcīgs)
Prognoze 12 mēnešiem	+3.93% upside

Dividendes
By Acuity
Dividenžu ienesīgums Sektora vidējais	0.31% 2.29%
Nākamie ieņēmumi	2026. g. 21. okt.
Nākamais dividenžu datums	2026. g. 15. okt.
Nākamais Ex dividenžu datums	2026. g. 15. sept.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	18B 213B
Iepriekšējā atvēršanas cena	591.49
Iepriekšējā slēgšanas cena	593.92

Ziņu noskaņojums

By Acuity

31%

69%

61 / 340 Rangs Healthcare

Thermo Fisher Scientific Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 7. aug. 23:01 UTC

Thermo Fisher Scientific Inc shares are trading lower in after-market hours. No specific news was identified to explain the decline.

2026. g. 6. aug. 19:46 UTC

Thermo Fisher Scientific Inc. shares are lower today, retracing from an earlier peak amid broader market influences from rising crude oil prices and Treasury yields.

2026. g. 5. aug. 19:56 UTC

Correlated Moves

News

Stifel raised its price target on Thermo Fisher Scientific to $650, boosting investor sentiment as shares trade higher. Charles River's strong performance may also influence results.

2026. g. 4. aug. 19:36 UTC

News

Correlated Moves

Thermo Fisher Scientific shares are lower amid concerns over organic revenue growth and declining margins, compounded by negative economic data and Bruker Corp's significant drop.

2026. g. 3. aug. 19:26 UTC

Thermo Fisher Scientific Inc. shares are higher today, tracking broader market gains amid falling energy prices and renewed investor confidence. No specific company news identified.

2026. g. 1. aug. 00:01 UTC

Thermo Fisher Scientific Inc shares are trading lower in after-market hours, reflecting a decline during the session despite being above the 20-day moving average.

2026. g. 31. jūl. 22:41 UTC

Correlated Moves

Thermo Fisher Scientific Inc. shares are lower in after-market trading, influenced by a broader market decline and rising U.S. Treasury yields amid inflation concerns.

2026. g. 30. jūl. 19:09 UTC

Correlated Moves

Thermo Fisher Scientific Inc shares are lower amid mixed economic data, including rising jobless claims and disappointing Q2 GDP growth.

2026. g. 29. jūl. 23:16 UTC

Thermo Fisher Scientific shares are trading roughly flat in after-market hours. The stock remains above its 20-day moving average and near its one-month range.

2026. g. 28. jūl. 18:06 UTC

News

Social Media

Thermo Fisher Scientific shares reached a 25-week high of $588.48, reflecting strong upward momentum despite a recent pullback from earlier session highs.

2026. g. 27. jūl. 18:01 UTC

Thermo Fisher Scientific Inc. shares are lower today amid a broader market reaction to falling oil prices, despite easing geopolitical tensions surrounding Iran.

2026. g. 24. jūl. 19:23 UTC

News

Social Media

Thermo Fisher Scientific shares are lower today despite strong Q2 results and revenue of $11.99 billion. Barclays and Deutsche Bank raised price targets to $650 and $635, respectively.

2026. g. 23. jūl. 23:01 UTC

Thermo Fisher Scientific shares declined in after-market trading, touching a session low before a slight recovery. The stock remains above its 20-day moving average.

2026. g. 22. jūl. 23:02 UTC

Social Media

Thermo Fisher Scientific is set to report earnings, with analysts estimating revenue of $11.71 billion and EPS of $5.72. Shares are higher in after-market trading.

2026. g. 21. jūl. 22:01 UTC

Thermo Fisher Scientific shares are higher in after-market hours, supported by positive market sentiment from strong earnings reports, despite recent lower finishes.

2026. g. 20. jūl. 19:46 UTC

Shares of Thermo Fisher Scientific Inc. are lower today, reflecting routine intraday fluctuations within the asset's one-month trading range.

Salīdzinājums

Cenas izmaiņa

Thermo Fisher Scientific Inc Prognoze

Cenas mērķis

By TipRanks

3.93% augšup

Prognoze 12 mēnešiem

Vidējais 617.35 USD 3.93%

Augstākais 690 USD

Zemākais 520 USD

Pamatojoties uz 18 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Thermo Fisher Scientific Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

18 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 18 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Thermo Fisher Scientific Inc — pēdējo 3 mēnešu laikā.

Noskaņojums

By Acuity

61 / 340 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar